Podophyllotoxin
| Clinical data | |
|---|---|
| Trade names | Condylox, Wartec, others | 
| Other names | (5R,5aR,8aR,9R)-9-hydroxy-5-(3,4,5-trimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d] [1,3]dioxol-6(5aH)-one | 
| AHFS/Drugs.com | Monograph | 
| MedlinePlus | a684055 | 
| Pregnancy category | 
 | 
| ATC code | |
| Legal status | |
| Legal status | 
 | 
| Pharmacokinetic data | |
| Elimination half-life | 1.0 to 4.5 hours. | 
| Identifiers | |
| 
 | |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.007.502 | 
| Chemical and physical data | |
| Formula | C22H22O8 | 
| Molar mass | 414.410 g·mol−1 | 
| 3D model (JSmol) | |
| Melting point | 183.3 to 184 °C (361.9 to 363.2 °F) | 
| 
 | |
| 
 | |
| (what is this?) (verify) | |
Podophyllotoxin (PPT) is the active ingredient in Podofilox, a medical cream used to treat genital warts and molluscum contagiosum. It is not recommended for HPV infections without external warts. It can be applied either by a healthcare provider or the patient themselves.
Podophyllotoxin is a non-alkaloid lignan extracted from the roots and rhizomes of plants of the genus Podophyllum. A less refined form known as podophyllum resin is also available, but has greater side effects.
Podophyllotoxin was first isolated in pure form in 1880 by Valerian Podwyssotzki (1818 – 28 January 1892), a Polish-Russian privatdozent at the University of Dorpat (now Tartu, Estonia) and assistant at the Pharmacological Institute there.
PPT is on the World Health Organization's List of Essential Medicines.